VIA Test Market Is Growing in Worldwide Cervical Cancer Market

USA, July 30, 2015 (Newswire.com) - Worldwide cervical cancer VIA test market is in novice but growing stage and mainly used in middle and low income countries where lack of resources and poorly organized health system are important factors for failure of effective screening for cervical cancer. VIA is simple, cost effective approach for cervical cancer screening. It does not require sophisticated equipment and can be done by trained health workers. The results of the test are available immediately making it an attractive approach for use in low resource settings. China and India are top contributor countries in the VIA test market.

Renub Research report titled "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report have been studied from 3 viewpoints.

1. Cervical cancer Test Population (2007-2020)

•  Pap smear test population (2007-2020)
•  HPV DNA test population (2007-2020)
•  VIA test Population (2007-2020)

2. Cervical Cancer Mortality Population (2001-2011)

3. Cervical Cancer Test Market (2007-2020)

•  Pap smear test market (2007-2020)
•  HPV DNA test market (2007-2020)
•  VIA test market (2007-2020)

All the 20 Countries studied in the report are as follows

1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia

Data Sources 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts. 

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. 

Click here to view the report Details: http://renub.com/report/cervical-cancer-test-market-patients---pap-smear-hpv-dna-via---test-patients---worldwide-131

For more information visit: http://www.renub.com/

Contact Us

Rajat Gupta
Sr. Manager - Publisher Relation
Email: [email protected] 
Phone:  +1-678-302-0700 (USA) +91-120-254-5750 (India)
Web: http://www.renub.com